01 1BSP Pharmaceuticals
01 1sacituzumab govitecan
01 1Italy
NDC Package Code : 43624-008
Start Marketing Date : 2020-04-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (180mg/180mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
87
PharmaCompass offers a list of Sacituzumab Govitecan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sacituzumab Govitecan manufacturer or Sacituzumab Govitecan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sacituzumab Govitecan manufacturer or Sacituzumab Govitecan supplier.
PharmaCompass also assists you with knowing the Sacituzumab Govitecan API Price utilized in the formulation of products. Sacituzumab Govitecan API Price is not always fixed or binding as the Sacituzumab Govitecan Price is obtained through a variety of data sources. The Sacituzumab Govitecan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sacituzumab Govitecan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sacituzumab Govitecan, including repackagers and relabelers. The FDA regulates Sacituzumab Govitecan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sacituzumab Govitecan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sacituzumab Govitecan supplier is an individual or a company that provides Sacituzumab Govitecan active pharmaceutical ingredient (API) or Sacituzumab Govitecan finished formulations upon request. The Sacituzumab Govitecan suppliers may include Sacituzumab Govitecan API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sacituzumab Govitecan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sacituzumab Govitecan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sacituzumab Govitecan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sacituzumab Govitecan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sacituzumab Govitecan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sacituzumab Govitecan suppliers with NDC on PharmaCompass.
We have 1 companies offering Sacituzumab Govitecan
Get in contact with the supplier of your choice:
